APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Hepatitis B Immunoglobulin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Hepatitis B Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173999790322 December 2025195 pages

Choose your research edition.

Industry ResearchHuman Hepatitis B Immunoglobulin Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Hepatitis B Immunoglobulin Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Human Hepatitis B Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Hepatitis B Immunoglobulin Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Hepatitis B Immunoglobulin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Human Hepatitis B Immunoglobulin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Human Hepatitis B Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Hepatitis B Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Hepatitis B Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Hepatitis B Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Hepatitis B Immunoglobulin include Shanghai Institute of Biological, China Biologic, Sichuan Yuanda Shuyang, Shanghai RAAS, Shuanglin Bio-pharmacy, Boya Bio-pharmaceutical, Hualan Biological, Tiantan Biologic and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Hepatitis B Immunoglobulin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Hepatitis B Immunoglobulin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Hepatitis B Immunoglobulin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Hepatitis B Immunoglobulin market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Hepatitis B Immunoglobulin Segment by Company

Shanghai Institute of Biological

China Biologic

Sichuan Yuanda Shuyang

Shanghai RAAS

Shuanglin Bio-pharmacy

Boya Bio-pharmaceutical

Hualan Biological

Tiantan Biologic

Bayer

Baxter

Octapharma

Grifols

CSL

Human Hepatitis B Immunoglobulin Segment by Type

400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)

200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)

100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)

Human Hepatitis B Immunoglobulin Segment by Application

Hepatitis B Carrier

Hepatitis B Close Contacts

Human Hepatitis B Immunoglobulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Hepatitis B Immunoglobulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Hepatitis B Immunoglobulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Hepatitis B Immunoglobulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Hepatitis B Immunoglobulin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Hepatitis B Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human Hepatitis B Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human Hepatitis B Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human Hepatitis B Immunoglobulin Industry Trends Table 2. Human Hepatitis B Immunoglobulin Industry Drivers Table 3. Human Hepatitis B Immunoglobulin Industry Opportunities and Challenges Table 4. Human Hepatitis B Immunoglobulin Industry Restraints Table 5. Global Human Hepatitis B Immunoglobulin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human Hepatitis B Immunoglobulin Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Human Hepatitis B Immunoglobulin Sales Market Share by Manufacturers Table 9. Global Human Hepatitis B Immunoglobulin Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Human Hepatitis B Immunoglobulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human Hepatitis B Immunoglobulin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human Hepatitis B Immunoglobulin Manufacturers, Product Type & Application Table 13. Global Human Hepatitis B Immunoglobulin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Hepatitis B Immunoglobulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Table 17. Major Manufacturers of 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Table 18. Major Manufacturers of 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Table 19. Global Human Hepatitis B Immunoglobulin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Human Hepatitis B Immunoglobulin Sales by Type (2021-2026) & (k units) Table 21. Global Human Hepatitis B Immunoglobulin Sales by Type (2027-2032) & (k units) Table 22. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2021-2026) Table 23. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2027-2032) Table 24. Global Human Hepatitis B Immunoglobulin Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Human Hepatitis B Immunoglobulin Revenue by Type (2021-2026) & (k units) Table 26. Global Human Hepatitis B Immunoglobulin Revenue by Type (2027-2032) & (k units) Table 27. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2021-2026) Table 28. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hepatitis B Carrier Table 30. Major Manufacturers of Hepatitis B Close Contacts Table 31. Global Human Hepatitis B Immunoglobulin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Human Hepatitis B Immunoglobulin Sales by Application (2021-2026) & (k units) Table 33. Global Human Hepatitis B Immunoglobulin Sales by Application (2027-2032) & (k units) Table 34. Global Human Hepatitis B Immunoglobulin Sales Market Share by Application (2021-2026) Table 35. Global Human Hepatitis B Immunoglobulin Sales Market Share by Application (2027-2032) Table 36. Global Human Hepatitis B Immunoglobulin Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Human Hepatitis B Immunoglobulin Revenue by Application (2021-2026) & (k units) Table 38. Global Human Hepatitis B Immunoglobulin Revenue by Application (2027-2032) & (k units) Table 39. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2021-2026) Table 40. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2027-2032) Table 41. Global Human Hepatitis B Immunoglobulin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Human Hepatitis B Immunoglobulin Sales by Region (2021-2026) & (k units) Table 43. Global Human Hepatitis B Immunoglobulin Sales Market Share by Region (2021-2026) Table 44. Global Human Hepatitis B Immunoglobulin Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Human Hepatitis B Immunoglobulin Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Human Hepatitis B Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Human Hepatitis B Immunoglobulin Sales by Country (2021-2026) & (k units) Table 48. North America Human Hepatitis B Immunoglobulin Sales by Country (2027-2032) & (k units) Table 49. Europe Human Hepatitis B Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Human Hepatitis B Immunoglobulin Sales by Country (2021-2026) & (k units) Table 51. Europe Human Hepatitis B Immunoglobulin Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Human Hepatitis B Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Human Hepatitis B Immunoglobulin Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Human Hepatitis B Immunoglobulin Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Human Hepatitis B Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Country (2027-2032) & (k units) Table 58. Global Human Hepatitis B Immunoglobulin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Human Hepatitis B Immunoglobulin Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Human Hepatitis B Immunoglobulin Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2021-2026) Table 62. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2027-2032) Table 63. Shanghai Institute of Biological Company Information Table 64. Shanghai Institute of Biological Business Overview Table 65. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Product Portfolio Table 67. Shanghai Institute of Biological Recent Development Table 68. China Biologic Company Information Table 69. China Biologic Business Overview Table 70. China Biologic Human Hepatitis B Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. China Biologic Human Hepatitis B Immunoglobulin Product Portfolio Table 72. China Biologic Recent Development Table 73. Sichuan Yuanda Shuyang Company Information Table 74. Sichuan Yuanda Shuyang Business Overview Table 75. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Product Portfolio Table 77. Sichuan Yuanda Shuyang Recent Development Table 78. Shanghai RAAS Company Information Table 79. Shanghai RAAS Business Overview Table 80. Shanghai RAAS Human Hepatitis B Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Shanghai RAAS Human Hepatitis B Immunoglobulin Product Portfolio Table 82. Shanghai RAAS Recent Development Table 83. Shuanglin Bio-pharmacy Company Information Table 84. Shuanglin Bio-pharmacy Business Overview Table 85. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Product Portfolio Table 87. Shuanglin Bio-pharmacy Recent Development Table 88. Boya Bio-pharmaceutical Company Information Table 89. Boya Bio-pharmaceutical Business Overview Table 90. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Product Portfolio Table 92. Boya Bio-pharmaceutical Recent Development Table 93. Hualan Biological Company Information Table 94. Hualan Biological Business Overview Table 95. Hualan Biological Human Hepatitis B Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Hualan Biological Human Hepatitis B Immunoglobulin Product Portfolio Table 97. Hualan Biological Recent Development Table 98. Tiantan Biologic Company Information Table 99. Tiantan Biologic Business Overview Table 100. Tiantan Biologic Human Hepatitis B Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Tiantan Biologic Human Hepatitis B Immunoglobulin Product Portfolio Table 102. Tiantan Biologic Recent Development Table 103. Bayer Company Information Table 104. Bayer Business Overview Table 105. Bayer Human Hepatitis B Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Bayer Human Hepatitis B Immunoglobulin Product Portfolio Table 107. Bayer Recent Development Table 108. Baxter Company Information Table 109. Baxter Business Overview Table 110. Baxter Human Hepatitis B Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Baxter Human Hepatitis B Immunoglobulin Product Portfolio Table 112. Baxter Recent Development Table 113. Octapharma Company Information Table 114. Octapharma Business Overview Table 115. Octapharma Human Hepatitis B Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Octapharma Human Hepatitis B Immunoglobulin Product Portfolio Table 117. Octapharma Recent Development Table 118. Grifols Company Information Table 119. Grifols Business Overview Table 120. Grifols Human Hepatitis B Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Grifols Human Hepatitis B Immunoglobulin Product Portfolio Table 122. Grifols Recent Development Table 123. CSL Company Information Table 124. CSL Business Overview Table 125. CSL Human Hepatitis B Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. CSL Human Hepatitis B Immunoglobulin Product Portfolio Table 127. CSL Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Human Hepatitis B Immunoglobulin Distributors List Table 131. Human Hepatitis B Immunoglobulin Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Human Hepatitis B Immunoglobulin Product Image Figure 2. Global Human Hepatitis B Immunoglobulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Hepatitis B Immunoglobulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Hepatitis B Immunoglobulin Sales (2021-2032) & (k units) Figure 5. Global Human Hepatitis B Immunoglobulin Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Human Hepatitis B Immunoglobulin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Image Figure 9. 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Image Figure 10. 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Image Figure 11. Global Human Hepatitis B Immunoglobulin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Human Hepatitis B Immunoglobulin Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2021-2032) Figure 14. Global Human Hepatitis B Immunoglobulin Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Human Hepatitis B Immunoglobulin Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2021-2032) Figure 17. Hepatitis B Carrier Image Figure 18. Hepatitis B Close Contacts Image Figure 19. Global Human Hepatitis B Immunoglobulin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Human Hepatitis B Immunoglobulin Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Human Hepatitis B Immunoglobulin Sales Market Share by Application (2021-2032) Figure 22. Global Human Hepatitis B Immunoglobulin Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Human Hepatitis B Immunoglobulin Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2021-2032) Figure 25. North America Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Human Hepatitis B Immunoglobulin Sales Market Share by Country (2021-2032) Figure 27. U.S. Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Country (2021-2032) Figure 32. Germany Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Human Hepatitis B Immunoglobulin Sales Market Share by Country (2021-2032) Figure 39. China Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Human Hepatitis B Immunoglobulin Sales Market Share by Country (2021-2032) Figure 47. Brazil Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Human Hepatitis B Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Human Hepatitis B Immunoglobulin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 58. North America Human Hepatitis B Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 60. Europe Human Hepatitis B Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Human Hepatitis B Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Human Hepatitis B Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Human Hepatitis B Immunoglobulin Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Human Hepatitis B Immunoglobulin Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
  • 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
  • 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Applications
  • Hepatitis B Carrier
  • Hepatitis B Close Contacts
Companies covered
  • Shanghai Institute of Biological
  • China Biologic
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Shuanglin Bio-pharmacy
  • Boya Bio-pharmaceutical
  • Hualan Biological
  • Tiantan Biologic
  • Bayer
  • Baxter
  • Octapharma
  • Grifols
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Hepatitis B Immunoglobulin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Hepatitis B Immunoglobulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human Hepatitis B Immunoglobulin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human Hepatitis B Immunoglobulin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human Hepatitis B Immunoglobulin Market Dynamics
  1. 2.1 Human Hepatitis B Immunoglobulin Industry Trends
  2. 2.2 Human Hepatitis B Immunoglobulin Industry Drivers
  3. 2.3 Human Hepatitis B Immunoglobulin Industry Opportunities and Challenges
  4. 2.4 Human Hepatitis B Immunoglobulin Industry Restraints
3 Human Hepatitis B Immunoglobulin Market by Manufacturers
  1. 3.1 Global Human Hepatitis B Immunoglobulin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human Hepatitis B Immunoglobulin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human Hepatitis B Immunoglobulin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human Hepatitis B Immunoglobulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Hepatitis B Immunoglobulin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human Hepatitis B Immunoglobulin Manufacturers, Product Type & Application
  7. 3.7 Global Human Hepatitis B Immunoglobulin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Hepatitis B Immunoglobulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Hepatitis B Immunoglobulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Hepatitis B Immunoglobulin Tier 1, Tier 2, and Tier 3
4 Human Hepatitis B Immunoglobulin Market by Type
  1. 4.1 Human Hepatitis B Immunoglobulin Type Introduction
  2. 4.1.1 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
  3. 4.1.2 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
  4. 4.1.3 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
  5. 4.2 Global Human Hepatitis B Immunoglobulin Sales by Type
  6. 4.2.1 Global Human Hepatitis B Immunoglobulin Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Human Hepatitis B Immunoglobulin Sales by Type (2021-2032)
  8. 4.2.3 Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2021-2032)
  9. 4.3 Global Human Hepatitis B Immunoglobulin Revenue by Type
  10. 4.3.1 Global Human Hepatitis B Immunoglobulin Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Human Hepatitis B Immunoglobulin Revenue by Type (2021-2032)
  12. 4.3.3 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2021-2032)
5 Human Hepatitis B Immunoglobulin Market by Application
  1. 5.1 Human Hepatitis B Immunoglobulin Application Introduction
  2. 5.1.1 Hepatitis B Carrier
  3. 5.1.2 Hepatitis B Close Contacts
  4. 5.2 Global Human Hepatitis B Immunoglobulin Sales by Application
  5. 5.2.1 Global Human Hepatitis B Immunoglobulin Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Human Hepatitis B Immunoglobulin Sales by Application (2021-2032)
  7. 5.2.3 Global Human Hepatitis B Immunoglobulin Sales Market Share by Application (2021-2032)
  8. 5.3 Global Human Hepatitis B Immunoglobulin Revenue by Application
  9. 5.3.1 Global Human Hepatitis B Immunoglobulin Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Human Hepatitis B Immunoglobulin Revenue by Application (2021-2032)
  11. 5.3.3 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2021-2032)
6 Global Human Hepatitis B Immunoglobulin Sales by Region
  1. 6.1 Global Human Hepatitis B Immunoglobulin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Hepatitis B Immunoglobulin Sales by Region (2021-2032)
  3. 6.2.1 Global Human Hepatitis B Immunoglobulin Sales by Region (2021-2026)
  4. 6.2.2 Global Human Hepatitis B Immunoglobulin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Hepatitis B Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human Hepatitis B Immunoglobulin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human Hepatitis B Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human Hepatitis B Immunoglobulin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human Hepatitis B Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human Hepatitis B Immunoglobulin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human Hepatitis B Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human Hepatitis B Immunoglobulin Revenue by Region
  1. 7.1 Global Human Hepatitis B Immunoglobulin Revenue by Region
  2. 7.1.1 Global Human Hepatitis B Immunoglobulin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human Hepatitis B Immunoglobulin Revenue by Region (2021-2026)
  4. 7.1.3 Global Human Hepatitis B Immunoglobulin Revenue by Region (2027-2032)
  5. 7.1.4 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human Hepatitis B Immunoglobulin Revenue (2021-2032)
  8. 7.2.2 North America Human Hepatitis B Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human Hepatitis B Immunoglobulin Revenue (2021-2032)
  11. 7.3.2 Europe Human Hepatitis B Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human Hepatitis B Immunoglobulin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human Hepatitis B Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human Hepatitis B Immunoglobulin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human Hepatitis B Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Institute of Biological
  2. 8.1.1 Shanghai Institute of Biological Company Information
  3. 8.1.2 Shanghai Institute of Biological Business Overview
  4. 8.1.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Product Portfolio
  6. 8.1.5 Shanghai Institute of Biological Recent Developments
  7. 8.2 China Biologic
  8. 8.2.1 China Biologic Company Information
  9. 8.2.2 China Biologic Business Overview
  10. 8.2.3 China Biologic Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 China Biologic Human Hepatitis B Immunoglobulin Product Portfolio
  12. 8.2.5 China Biologic Recent Developments
  13. 8.3 Sichuan Yuanda Shuyang
  14. 8.3.1 Sichuan Yuanda Shuyang Company Information
  15. 8.3.2 Sichuan Yuanda Shuyang Business Overview
  16. 8.3.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Product Portfolio
  18. 8.3.5 Sichuan Yuanda Shuyang Recent Developments
  19. 8.4 Shanghai RAAS
  20. 8.4.1 Shanghai RAAS Company Information
  21. 8.4.2 Shanghai RAAS Business Overview
  22. 8.4.3 Shanghai RAAS Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai RAAS Human Hepatitis B Immunoglobulin Product Portfolio
  24. 8.4.5 Shanghai RAAS Recent Developments
  25. 8.5 Shuanglin Bio-pharmacy
  26. 8.5.1 Shuanglin Bio-pharmacy Company Information
  27. 8.5.2 Shuanglin Bio-pharmacy Business Overview
  28. 8.5.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Product Portfolio
  30. 8.5.5 Shuanglin Bio-pharmacy Recent Developments
  31. 8.6 Boya Bio-pharmaceutical
  32. 8.6.1 Boya Bio-pharmaceutical Company Information
  33. 8.6.2 Boya Bio-pharmaceutical Business Overview
  34. 8.6.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Product Portfolio
  36. 8.6.5 Boya Bio-pharmaceutical Recent Developments
  37. 8.7 Hualan Biological
  38. 8.7.1 Hualan Biological Company Information
  39. 8.7.2 Hualan Biological Business Overview
  40. 8.7.3 Hualan Biological Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hualan Biological Human Hepatitis B Immunoglobulin Product Portfolio
  42. 8.7.5 Hualan Biological Recent Developments
  43. 8.8 Tiantan Biologic
  44. 8.8.1 Tiantan Biologic Company Information
  45. 8.8.2 Tiantan Biologic Business Overview
  46. 8.8.3 Tiantan Biologic Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Tiantan Biologic Human Hepatitis B Immunoglobulin Product Portfolio
  48. 8.8.5 Tiantan Biologic Recent Developments
  49. 8.9 Bayer
  50. 8.9.1 Bayer Company Information
  51. 8.9.2 Bayer Business Overview
  52. 8.9.3 Bayer Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bayer Human Hepatitis B Immunoglobulin Product Portfolio
  54. 8.9.5 Bayer Recent Developments
  55. 8.10 Baxter
  56. 8.10.1 Baxter Company Information
  57. 8.10.2 Baxter Business Overview
  58. 8.10.3 Baxter Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Baxter Human Hepatitis B Immunoglobulin Product Portfolio
  60. 8.10.5 Baxter Recent Developments
  61. 8.11 Octapharma
  62. 8.11.1 Octapharma Company Information
  63. 8.11.2 Octapharma Business Overview
  64. 8.11.3 Octapharma Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Octapharma Human Hepatitis B Immunoglobulin Product Portfolio
  66. 8.11.5 Octapharma Recent Developments
  67. 8.12 Grifols
  68. 8.12.1 Grifols Company Information
  69. 8.12.2 Grifols Business Overview
  70. 8.12.3 Grifols Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Grifols Human Hepatitis B Immunoglobulin Product Portfolio
  72. 8.12.5 Grifols Recent Developments
  73. 8.13 CSL
  74. 8.13.1 CSL Company Information
  75. 8.13.2 CSL Business Overview
  76. 8.13.3 CSL Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CSL Human Hepatitis B Immunoglobulin Product Portfolio
  78. 8.13.5 CSL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Hepatitis B Immunoglobulin Value Chain Analysis
  2. 9.1.1 Human Hepatitis B Immunoglobulin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Hepatitis B Immunoglobulin Production Mode & Process
  6. 9.2 Human Hepatitis B Immunoglobulin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Hepatitis B Immunoglobulin Distributors
  9. 9.2.3 Human Hepatitis B Immunoglobulin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst